Clinical interest in motilin includes the long standing use of erythromycin, an antibiotic with motilin receptor (MLNR) agonist activity, to treat intestinal dysmotility conditions such as gastroparesis (5, 6). This evidence concerns the gene MLNR and gastroparesis.